Alcohol Consumption Increases Risk Of Lobular And HR+ Breast Cancer
Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer
Brothers Of Prostate Cancer Patients At Risk Of Diagnosis
Estrogen Alone Didn’t Increase Lung Cancer Mortality In WHI
Tumors Harder To Detect In Women In Their Forties
Two Avastin Trials Show OS Benefit In Advanced Disease
Risk-Benefit Analysis Advised Prior To Hormone Therapy
Elderly Patients Fail To Receive New Cancer Therapy For CML
Rising Obesity May Result In Higher Cancer Incidence
Study Finds Relationship Between Meat Intake, Cancer
Radiation To Stem Cell Niche Improved PFS In Glioblastoma
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
